0001062993-24-001252.txt : 20240124 0001062993-24-001252.hdr.sgml : 20240124 20240124172110 ACCESSION NUMBER: 0001062993-24-001252 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240122 FILED AS OF DATE: 20240124 DATE AS OF CHANGE: 20240124 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mehalik Daniella CENTRAL INDEX KEY: 0002003597 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13738 FILM NUMBER: 24557711 MAIL ADDRESS: STREET 1: 100 HALE STREET CITY: NEWBURYPORT STATE: MA ZIP: 01950 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PSYCHEMEDICS CORP CENTRAL INDEX KEY: 0000806517 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 581701987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 125 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: 978-206-8220 MAIL ADDRESS: STREET 1: 125 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2024-01-22 0000806517 PSYCHEMEDICS CORP PMD 0002003597 Mehalik Daniella C/O PSYCHEMEDICS CORPORATION 289 GREAT ROAD, SUITE 200 ACTON MA 01720 0 1 0 0 Vice President - Finance 0 Stock Option (Right to Buy) 3.40 2024-01-22 4 A 0 35000 0 A 2034-01-22 Common Stock, $.005 Par Value 35000 35000 D Stock Option (Right to Buy) 3.40 2024-01-22 4 A 0 70000 0 A 2034-01-22 Common Stock, $.005 Par Value 70000 70000 D The option becomes exercisable with respect to 50% of the shares on January 22, 2025 and with respect to the remaining 50% on January 22, 2026. The option becomes exercisable, if at all, in two 35,000 share increments. The first increment of 35,000 shares becomes exercisable at the time the weighted average daily price of Psychemedics common stock on the Nasdaq Stock Market during any consecutive 60 calendar day period ending on or before January 22, 2027 shall have exceeded $5.50. The second increment of 35,000 shares becomes exercisable at the time the weighted average daily price of Psychemedics common stock on the Nasdaq Stock Market during any consecutive 60 calendar day period ending on or before January 22, 2028 shall have exceeded $6.50. Patrick J. Kinney, Jr. as attorney-in-fact for Daniella Mehalik 2024-01-24